Your Health Journey is Unique, So are your Goals

Compounded Tirzepatide at GobyMeds

At GobyMeds, we know every wellness journey is different — and your medication should reflect that. Our compounded tirzepatide is designed with your unique needs in mind.

From flexible dosing that matches your goals to thoughtfully selected additives that support energy, digestion, and comfort, your tirzepatide formula is crafted just for you. This isn’t a one-size-fits-all prescription - it’s a personalized tool to help you feel your best, every step of the way.

Compounded Semaglutide & Compounded Tirzepatide

Weight Loss Programs

Compounded Semaglutide (GLP-1)
Starter Plan - 12 week Bundle

$349

Perfect for first-time patients beginning their GLP-1 journey.

BLACK FRIDAY PRICE: $279*

($93/month)*

Compounded Semaglutide (GLP-1)
12-Week Bundle

$549

Ideal for patients at a higher non-starter dose or wanting to titrate up to a higher therapeutic dose.

BLACK FRIDAY PRICE: $439*

($146/month)*

Compounded Semaglutide (GLP-1)
Single Month

$199

One month at any dosage.

BLACK FRIDAY PRICE: $159*

*Black Friday Pricing

This price is available now through December 7th, 2025 with code BLACKFRIDAY20
‍Click here for more details.

Compounded Tirzepatide (GLP-1/GIP)
Starter Plan - 3 month

$499

Perfect for first-time patients beginning their weight loss journey.

BLACK FRIDAY PRICE: $399*

($133/month)*

Compounded Tirzepatide (GLP-1/GIP)
12-Week Bundle

$599+

Ideal for patients at a higher non-starter dose or wanting to titrate up to a higher therapeutic dose.

BLACK FRIDAY PRICE: $479+*

(price dependent on dose)

Compounded Tirzepatide (GLP-1/GIP)
Single Month

$349

One month at any dosage.

BLACK FRIDAY PRICE: $279*

*Black Friday Pricing

This price is available now through December 7th, 2025 with code BLACKFRIDAY20
Click here for more details.

Zepbound^®

$1399 / month

Zepbound^® is a GLP-1/GIP medication designed to help adults achieve clinically proven weight-loss results.

Wegovy^®

$1695 / month

Wegovy^® is a GLP-1 medication designed to help adults achieve clinically proven weight-loss results.

Get Started Now

SAVE 20% with code blackfriday20

SAVE 20% with code blackfriday20

SAVE 20% with code blackfriday20

SAVE 20% with code blackfriday20

SAVE 20% with code blackfriday20

Offer ends December 7th, 2025. Click here for more details.

How It Works

Tirzepatide is a safe and effective medication classified as a dual glucose-dependent insulinotropic polypeptide (GIP) and GLP-1 receptor agonist. It mimics the functions of both GIP and glucagon-like peptide-1 (GLP-1) hormones in the body. This dual action helps regulate blood sugar levels by enhancing insulin release and reducing the production of glucagon, a hormone that typically raises blood sugar levels.

About This Product

This product is priced to include 4 weekly injections of the medication, cost of the prescription written by a medical professional, and refrigerated overnight shipping from our 503(a) & 503(b) certified pharmacy partner, directly to you. No hidden fees, membership, or subscription required.

Why Choose Compounded Tirzepatide?

This once-weekly compounded tirzepatide weight loss injection that effectively reduces appetite and "food noise", helping you lose more weight compared to dieting alone¹. Compounded tirzepatide is the same active ingredient as the brand-name medications below:

Benefits of Tirzepatide
tirzepatide is an injectable medication that can help treat type 2 diabetes and leads to weight loss and appetite control.
‍
Weight Loss +
Compounded tirzepatide has demonstrated the ability to reduce body mass by up to 20%.
‍

Safety Information

To see important safety information regarding the use of compounded tirzepatide, click here.

The Science of GLP-1 Meds

¹ Aronne LJ, Fujioka K, Aroda VR, et al. Effect of tirzepatide on maintenance of weight reduction in participants with obesity: A randomized, double-blind, phase 3 trial. JAMA. 2023;331(1):45-56. doi:10.1001/jama.2023.0149. 20-25% average weight loss (Tirzepatide Plan)
‍
‍
² Wilding JPH, Batterham RL, Calanna S, et al. Once-weekly semaglutide in adults with overweight or obesity. N Engl J Med. 2021;384(11):989-1002. doi:10.1056/NEJMoa2032183.
‍15-20% average weight loss (Semaglutide Plan)
³ "Drug Trial Snapshot" U.S. Food and Drug Administration, 5 Dec. 2017
⁴ For the treatment of adult patients with type 2 diabetes mellitus to improve glycemic control, in combination with metformin (second-line treatment), and in combination with metformin and sulfonylurea (third-line treatment)

‍^‍‍